Clinical Trials Browser

Phase 3 × Active not recruiting × Uterine Cervical Neoplasms × Clear all

NCT02466971 2026-03-18

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Phase 3 Active not recruiting

450 enrolled 11 charts

Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT04982237 2025-11-19

A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 3 Active not recruiting

445 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02834637 2025-09-10

DoRIS

Phase 3 Active not recruiting

930 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04906993 2025-09-09

Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer

Phase 3 Active not recruiting

443 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05056402 2025-07-22

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Phase 3 Active not recruiting

1,382 enrolled

Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT01566240 2024-12-05

INTERLACE

Phase 3 Active not recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04723875 2024-11-01

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

Phase 3 Active not recruiting

306 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05662020 2022-12-27

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Phase 3 Active not recruiting

2,750 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections